Brown M S, Goldstein J L
J Investig Med. 1996 Feb;44(2):14-23.
When Michael S. Brown, MD and Joseph L. Goldstein, MD first met as interns at the Massachusetts General Hospital in 1966, they could hardly have imagined that their careers would continue to be intertwined some 30 years later. It was shortly following their arrival as clinical associates at the National Institutes of Health in 1968 that the pair developed an interest in abnormalities of cholesterol metabolism. Bolstered by epidemiologic data that showed elevated cholesterol levels in many patients with myocardial infarction, Brown and Goldstein, who relocated to the University of Texas Southwestern Medical Center in 1972, began a search for receptors important in cholesterol homeostasis. These studies, performed in their early stages while juggling clinical duties at Parkland Hospital, culminated in a series of scientific achievements which merited among other honors the Hazen Award in 1982, the Lasker Award in 1985, and the Nobel Prize in Medicine in 1985. Today, as Regental Professors of the University of Texas, Brown and Goldstein head a laboratory group which continues to test the cutting edge of medical research. Although impressed with the pace of technological advances in biology, the declining role of clinically oriented physicians in biomedical research troubles the pair. Interviewed in their library in Dallas, Brown and Goldstein spoke about the complicated balance of science, medicine, and education necessary to produce another generation of successful investigators.
1966年,医学博士迈克尔·S·布朗和医学博士约瑟夫·L·戈尔茨坦作为实习生在马萨诸塞州综合医院初次见面时,他们几乎无法想象大约30年后他们的职业生涯仍会交织在一起。1968年,他们作为临床助理来到美国国立卫生研究院后不久,便对胆固醇代谢异常产生了兴趣。有流行病学数据显示,许多心肌梗死患者的胆固醇水平升高,这为他们提供了支持。1972年,布朗和戈尔茨坦搬到了得克萨斯大学西南医学中心,开始寻找在胆固醇稳态中起重要作用的受体。这些研究是在他们早期进行的,当时他们还兼顾着帕克兰医院的临床工作,最终取得了一系列科学成就,这些成就为他们赢得了诸多荣誉,包括1982年的哈森奖、1985年的拉斯克奖以及1985年的诺贝尔医学奖。如今,作为得克萨斯大学的特聘教授,布朗和戈尔茨坦领导着一个实验室团队,该团队继续探索医学研究的前沿领域。尽管对生物学技术进步的速度印象深刻,但临床导向型医生在生物医学研究中作用的下降让他们感到困扰。在达拉斯他们的书房接受采访时,布朗和戈尔茨坦谈到了培养新一代成功研究人员所需的科学、医学和教育之间复杂的平衡。